Skip to main content
Top
Published in: Intensive Care Medicine 4/2013

Open Access 01-04-2013 | Original

Effects of infection control measures on acquisition of five antimicrobial drug-resistant microorganisms in a tetanus intensive care unit in Vietnam

Authors: Constance Schultsz, Martinus C. J. Bootsma, Huynh T. Loan, Tran T. T. Nga, Le T. P. Thao, Tran T. D. Thuy, James Campbell, Le M. Vien, Ngo T. Hoa, Nguyen V. M. Hoang, Ferdinand Wit, Nguyen V. V. Chau, Jeremy Farrar, Marc J. M. Bonten, Lam M. Yen

Published in: Intensive Care Medicine | Issue 4/2013

Login to get access

Abstract

Purpose

To quantify the effects of barrier precautions and antibiotic mixing on prevalence and acquisition of five drug-resistant microorganisms within a single tetanus intensive care unit at a tertiary referral hospital in Ho Chi Minh City, Vietnam.

Methods

All patients admitted within the study period were included. After a 1-year baseline period, barrier precautions were implemented and the single empirical treatment ceftazidime was changed to mixing (per consecutive patient) of three different regimens (ceftazidime, ciprofloxacin, piperacillin–tazobactam). Markov chain modeling and genotyping were used to determine the effects of interventions on prevalence levels and the relative importance of cross-transmission and antibiotic-associated selection.

Results

A total of 190 patients were included in year 1 (2,708 patient days, 17,260 cultures) and 167 patients in year 2 (3,384 patient days, 20,580 cultures). In year 1, average daily prevalence rates for methicillin-resistant Staphylococcus aureus (MRSA), extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae (excluding Klebsiella pneumoniae), Pseudomonas aeruginosa, gentamicin-resistant K. pneumoniae, and amikacin-resistant Acinetobacter species were 34.0, 61.3, 53.4, 65.7 and 57.1 %. After intervention, ceftazidime usage decreased by 53 %; the use of piperacillin–tazobactam and ciprofloxacin increased 7.2-fold and 4.5-fold, respectively. Adherence to hand hygiene after patient contact was 54 %. These measures were associated with a reduction of MRSA prevalence by 69.8 % (to 10.3 %), mainly because of less cross-transmission (88 % reduction), and of ESBL-producing Enterobacteriaceae prevalence by 10.3 % (non-significantly). In contrast, prevalence levels of the other three pathogens remained unaffected.

Conclusion

The combination of simple infection control measures and antibiotic mixing was highly effective in reducing the prevalence of MRSA, but not of Gram-negative microorganisms.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, Cuellar LE, Arikan OA, Abouqal R, Leblebicioglu H (2006) Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 145(8):582–591PubMed Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, Cuellar LE, Arikan OA, Abouqal R, Leblebicioglu H (2006) Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 145(8):582–591PubMed
2.
go back to reference Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA (2005) Hospital-acquired neonatal infections in developing countries. Lancet 36:1175–1188CrossRef Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA (2005) Hospital-acquired neonatal infections in developing countries. Lancet 36:1175–1188CrossRef
3.
go back to reference Basu S, Andrews JR, Poolman EM, Gandhi NR, Shah NS, Moll A, Moodley P, Galvani AP, Friedland GH (2007) Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet 370:1500–1507PubMedCrossRef Basu S, Andrews JR, Poolman EM, Gandhi NR, Shah NS, Moll A, Moodley P, Galvani AP, Friedland GH (2007) Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet 370:1500–1507PubMedCrossRef
4.
5.
go back to reference Raza MW, Kazi BM, Mustafa M, Gould FK (2004) Developing countries have their own characteristic problems with infection control. J Hosp Infect 57:294–299PubMedCrossRef Raza MW, Kazi BM, Mustafa M, Gould FK (2004) Developing countries have their own characteristic problems with infection control. J Hosp Infect 57:294–299PubMedCrossRef
6.
go back to reference Vincent J-L, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, for the EIIGoI (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323–2329PubMedCrossRef Vincent J-L, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, for the EIIGoI (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323–2329PubMedCrossRef
7.
go back to reference Lipsitch M, Samore MH (2002) Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 8:347–354PubMedCrossRef Lipsitch M, Samore MH (2002) Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 8:347–354PubMedCrossRef
8.
go back to reference Harris AD, Lautenbach E, Perencevich E (2005) A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance. Clin Infect Dis 41:77–82PubMedCrossRef Harris AD, Lautenbach E, Perencevich E (2005) A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance. Clin Infect Dis 41:77–82PubMedCrossRef
9.
go back to reference Bootsma MC, Bonten MJ, Nijssen S, Fluit AC, Diekmann O (2007) An algorithm to estimate the importance of bacterial acquisition routes in hospital settings. Am J Epidemiol 166:841–851PubMedCrossRef Bootsma MC, Bonten MJ, Nijssen S, Fluit AC, Diekmann O (2007) An algorithm to estimate the importance of bacterial acquisition routes in hospital settings. Am J Epidemiol 166:841–851PubMedCrossRef
10.
go back to reference Thwaites CL, Yen LM, Glover C, Tuan PQ, Nga NT, Parry J, Loan HT, Bethell D, Day NP, White NJ, Soni N, Farrar JJ (2006) Predicting the clinical outcome of tetanus: the Tetanus Severity Score. Trop Med Int Health 11:279–287PubMedCrossRef Thwaites CL, Yen LM, Glover C, Tuan PQ, Nga NT, Parry J, Loan HT, Bethell D, Day NP, White NJ, Soni N, Farrar JJ (2006) Predicting the clinical outcome of tetanus: the Tetanus Severity Score. Trop Med Int Health 11:279–287PubMedCrossRef
11.
go back to reference Nijssen S, Bootsma M, Bonten M (2006) Potential confounding in evaluating infection-control interventions in hospital settings: changing antibiotic prescription. Clin Infect Dis 43:616–623PubMedCrossRef Nijssen S, Bootsma M, Bonten M (2006) Potential confounding in evaluating infection-control interventions in hospital settings: changing antibiotic prescription. Clin Infect Dis 43:616–623PubMedCrossRef
12.
go back to reference Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM (2003) SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 24:362–386PubMedCrossRef Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM (2003) SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 24:362–386PubMedCrossRef
13.
go back to reference Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth G, Lai R, Ebrahim S (2004) Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 329:533PubMedCrossRef Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth G, Lai R, Ebrahim S (2004) Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 329:533PubMedCrossRef
14.
go back to reference Allegranzi B, Pittet D (2009) Role of hand hygiene in healthcare-associated infection prevention. J Hosp Infect 73:305–315PubMedCrossRef Allegranzi B, Pittet D (2009) Role of hand hygiene in healthcare-associated infection prevention. J Hosp Infect 73:305–315PubMedCrossRef
15.
go back to reference de Man P, Verhoeven BA, Verbrugh HA, Vos MC, van den Anker JN (2000) An antibiotic policy to prevent emergence of resistant bacilli. Lancet 355:973–978PubMedCrossRef de Man P, Verhoeven BA, Verbrugh HA, Vos MC, van den Anker JN (2000) An antibiotic policy to prevent emergence of resistant bacilli. Lancet 355:973–978PubMedCrossRef
16.
go back to reference Bantar C, Vesco E, Heft C, Salamone F, Krayeski M, Gomez H, Coassolo MA, Fiorillo A, Franco D, Arango C, Duret F, Oliva ME (2004) Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: impact on sustained high rates of bacterial resistance. Antimicrob Agents Chemother 48:392–395PubMedCrossRef Bantar C, Vesco E, Heft C, Salamone F, Krayeski M, Gomez H, Coassolo MA, Fiorillo A, Franco D, Arango C, Duret F, Oliva ME (2004) Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: impact on sustained high rates of bacterial resistance. Antimicrob Agents Chemother 48:392–395PubMedCrossRef
17.
go back to reference Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS (2007) Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children’s hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother 60:629–637PubMedCrossRef Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS (2007) Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children’s hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother 60:629–637PubMedCrossRef
18.
go back to reference Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, Mariano N, Marks S, Burns JM, Dominick D, Lim M (1998) Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280:1233–1237PubMedCrossRef Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, Mariano N, Marks S, Burns JM, Dominick D, Lim M (1998) Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280:1233–1237PubMedCrossRef
19.
go back to reference Martinez JA, Nicolas JM, Marco F, Horcajada JP, Garcia-Segarra G, Trilla A, Codina C, Torres A, Mensa J (2006) Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units. Crit Care Med 34:329–336PubMedCrossRef Martinez JA, Nicolas JM, Marco F, Horcajada JP, Garcia-Segarra G, Trilla A, Codina C, Torres A, Mensa J (2006) Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units. Crit Care Med 34:329–336PubMedCrossRef
20.
go back to reference van Loon HJ, Vriens MR, Fluit AC, Troelstra A, van der Werken C, Verhoef J, Bonten MJ (2005) Antibiotic rotation and development of gram-negative antibiotic resistance. Am J Respir Crit Care Med 171:480–487PubMedCrossRef van Loon HJ, Vriens MR, Fluit AC, Troelstra A, van der Werken C, Verhoef J, Bonten MJ (2005) Antibiotic rotation and development of gram-negative antibiotic resistance. Am J Respir Crit Care Med 171:480–487PubMedCrossRef
21.
go back to reference Kollef MH (2006) Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit? Clin Infect Dis 43(Suppl 2):S82–S88PubMedCrossRef Kollef MH (2006) Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit? Clin Infect Dis 43(Suppl 2):S82–S88PubMedCrossRef
22.
go back to reference Bonten MJ, Weinstein RA (2006) Antibiotic cycling in intensive care units: the value of organized chaos? Crit Care Med 34:549–551PubMedCrossRef Bonten MJ, Weinstein RA (2006) Antibiotic cycling in intensive care units: the value of organized chaos? Crit Care Med 34:549–551PubMedCrossRef
23.
go back to reference Le TM, Baker S, Le TP, Le TP, Cao TT, Tran TT, Nguyen VM, Campbell JI, Lam MY, Nguyen TH, Nguyen VV, Farrar J, Schultsz C (2009) High prevalence of plasmid-mediated quinolone resistance determinants in commensal members of the Enterobacteriaceae in Ho Chi Minh City Vietnam. J Med Microbiol 58:1585–1592PubMedCrossRef Le TM, Baker S, Le TP, Le TP, Cao TT, Tran TT, Nguyen VM, Campbell JI, Lam MY, Nguyen TH, Nguyen VV, Farrar J, Schultsz C (2009) High prevalence of plasmid-mediated quinolone resistance determinants in commensal members of the Enterobacteriaceae in Ho Chi Minh City Vietnam. J Med Microbiol 58:1585–1592PubMedCrossRef
Metadata
Title
Effects of infection control measures on acquisition of five antimicrobial drug-resistant microorganisms in a tetanus intensive care unit in Vietnam
Authors
Constance Schultsz
Martinus C. J. Bootsma
Huynh T. Loan
Tran T. T. Nga
Le T. P. Thao
Tran T. D. Thuy
James Campbell
Le M. Vien
Ngo T. Hoa
Nguyen V. M. Hoang
Ferdinand Wit
Nguyen V. V. Chau
Jeremy Farrar
Marc J. M. Bonten
Lam M. Yen
Publication date
01-04-2013
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 4/2013
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-012-2771-1

Other articles of this Issue 4/2013

Intensive Care Medicine 4/2013 Go to the issue